Publications by authors named "Zainab Safar"
Vaccines (Basel)
March 2024
Article Synopsis
- Hepatitis B virus (HBV) infection can worsen chronic conditions like hepatitis and cirrhosis, and patients with inflammatory bowel disease (IBD) on biologic therapies may face increased risk of HBV reactivation.
- A study was conducted to compare HBV vaccination effectiveness between ulcerative colitis (UC) patients treated with infliximab (IFX) and those on 5-aminosalicylic acid (5-ASA).
- Results showed that patients on 5-ASA had significantly higher HBV antibody levels, making them more likely to respond effectively to the vaccine, highlighting the need for increased HBV vaccination effort prior to starting IFX therapy.*
